Clinical Trial Update: Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hyaluronic Acid 0.3% (FBV_01) vs Hyaluronic Acid 0.3% in Subjects in the Treatment From Moderate to Severe DED [NA]

View source ↗

Summary

This recruiting clinical trial compares a tear substitute (FBV_01) containing an ancillary medicinal substance plus hyaluronic acid 0.3% against hyaluronic acid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Dry Eye Syndrome

Drugs mentioned

• FBV_01 tear substitute with ancillary medicinal substance
• Hyaluronic Acid 0.3% (hyaluronic acid)

Snippet

Sponsor: FB Vision S.p.A | Conditions: Dry Eye Syndromes, Dry Eye Disease (DED) | NA | Status: RECRUITING